Showing results (1-10 of 1,046) with videos related to
Sort By:
Pageof 105
Clinical Pharmacology and Therapeutics|April 1, 1982
Oxaprozin disposition in renal diseaseS T Chiang, G Morrison, J A Knowles, et al.Journal of Clinical Pharmacology|August 1, 1984
Effects of food on oxaprozin bioavailabilityS T Chiang, J A Knowles, J A Hubsher, et al.Clinical Pharmacology and Therapeutics|May 1, 1984
Effect of renal impairment and hemodialysis on lorazepam kineticsG Morrison, S T Chiang, H H Koepke, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1978
Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeysF W Janssen, S K Kirkman, J A Knowles, et al.Clinical Pharmacology and Therapeutics|September 1, 1988
Effect of chronic renal failure on oxaprozin multiple-dose pharmacokineticsP R Audet, J A Knowles, S M Troy, et al.Journal of Pharmaceutical Sciences|June 1, 1982
Gas chromatographic determination of guanabenz in biological fluids by electron-capture detectionJ A Knowles, G R White, C J Kick, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1987
Extrapolation from animals to man: predictions, pitfalls and perspectivesH W RueliusThe Journal of Clinical Psychiatry|October 1, 1978
Comparative metabolism of lorazepam in man and four animal speciesH W RueliusDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1979
Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzymic hydrolysisH W Ruelius, C O Tio, J A Knowles, et al.Journal of Clinical Pharmacology|August 1, 1977
Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary resultsD J Greenblatt, W H Comer, H W Elliott, et al.Pageof 105